期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

树突状细胞与宫颈癌免疫治疗的研究进展 被引量：2

下载PDF
导出
摘要 宫颈癌是妇女最常见恶性肿瘤之一,仅次于乳腺癌位居第二位。研究证明人乳头瘤病毒(HPV)感染是宫颈癌主要危险因素。树突状细胞(DC)是目前发现最有潜力、功能最强大、惟一能激活原始T细胞的抗原递呈细胞(APC),能够有效引发一系列抗肿瘤特异性免疫应答。随着分子生物学、免疫学的研究进展,以DC为基础的宫颈癌疫苗的研究取得了突破性进展。就DC与宫颈癌免疫治疗之间的关系综述。
作者 盛敏佳 李楷滨 王立岩
机构地区 吉林大学中日联谊医院妇产科
出处 《国外医学（妇产科学分册）》 CAS 2004年第4期214-217,共4页 Foreign Medical Sciences(Obstet Gynecol Fascicle)
关键词 树突状细胞 宫颈癌 免疫治疗 恶性肿瘤
分类号 R737.33 [医药卫生—肿瘤]
  • 相关文献

参考文献20

  • 1Maldonado LR, Moser M. Dendritic cell subsets and the regulation of Th1/Th2 responses. Semin Immunol, 2001, 13(5): 275-282.
  • 2Kim DK, Lee TV, Castilleja A, et al. Folate binding protein peptide 191-199 presented on dendritic cells can stimulate CTL from ovarian and breast cancer patients. Anticancer Res, 1999,19: 2907-2916.
  • 3Hermans IF, Ritchie DS, Yang JP, et al. CD8^+ T cell-dependent limitation of dendritic cells in vivo limits the induction of antitumor immunity. J Imnunol, 2000, 164(6): 3095-3101.
  • 4Mendoza L, Bubenk J, Smov J, et al. Tumor-inhibitory effects of dendritic cells administered at the site of HPV 16-induced neoplasms.Folia Biol (Praha), 2002, 48(3): 114-119.
  • 5Yao V, Platell C, Hall JC. Dendritic cells. A N Z J Surg, 2002, 72(7):501-506.
  • 6Furumoto H, Irahara M. Human papilloma virus(HPV) and cervical cancer. J Med Invest,2002, 49(3-4): 124-133.
  • 7Tindle RW. Immune evasion in human papillomavirus-associated cervical cancer. Nat Rev Cancer, 2002, 2(1): 59-65.
  • 8Heinemann L, Dillon,S, Crawford A, et al. Flow cytometric quantitation of the protective efficacy of dendritic cell based vaccines in a human papillomavirus type 16 murine challenge model. J Virol Methods, 2004, 117(1):9-18.
  • 9Mandic A, Vujkov T. Human papillomavirus vaccine as a new way of preventing cervical cancer: a dream or the future? Ann Oncol, 2004,15(2): 197-200.
  • 10Tobery TW, Smith JF, Kuklin N,et al. Effect of vaccine delivery system on the induction of HPV 16Ll-specific humoral and cell-mediated immune responses in immunized rhesus macaques. Vaccine,2003, 21(13-14):1539-1547.

同被引文献24

  • 1徐道华,夏永鹏,邱宗荫.子宫颈癌治疗性疫苗研究进展[J].免疫学杂志,2004,20(z1):46-49. 被引量：4
  • 2徐道华,夏永鹏,邱宗荫,吴玉章,贾正才,邹丽云,周伟.宫颈癌治疗性疫苗的设计、合成及其生物学效应[J].免疫学杂志,2004,20(6):446-449. 被引量：2
  • 3徐道华,夏永鹏,邱宗荫,吴玉章,贾正才,邹丽云,周伟.γ干扰素对宫颈癌治疗性脂肽疫苗抗肿瘤作用的研究[J].现代医药卫生,2004,20(23):2479-2480. 被引量：2
  • 4安菊生.树突状细胞为基础的疫苗治疗宫颈癌:一项15例患者个体化治疗的临床实验结果[J].国外医学（妇产科学分册）,2004,31(6):388-389. 被引量：1
  • 5Shibuya K,Mathers CD,Boschi-Pinto C, et al.Global and regional estimates of cancer mortality and incidence by site: II. Results for the global burden of disease 2000[J] .BMC Cancer,2002,2(1) :37.
  • 6Stanley M. Papillomavirus: biology and clinical implication for immunotherapy[J]. Mol Med Roday, 1997, 3(6) :239.
  • 7Huh JJ, Wolf JK, Fightmaster DL, et al. Trandsduction of adenovirusmediated wild-type p53 after radiotherapy in human cervical cancer cells [ J ]. Gynecol Oncol, 2003,89 (2):243-250.
  • 8Bilsland AE, Anderson C J, Flectcher Monagban A J, et al. Selective ablation of human cancer cells by elomerase-specific adenoviral suicide gene theraphy vectors expressing bacterial nitroreductase [J]. Oncogene, 2003,22(3):370-380.
  • 9Tindle RW. Immune cvasion in human papillomavirus-associated cervical cancer[ J]. Nat Rev Cancer, 2002,2 ( 1 ) : 59-65.
  • 10Heinenmnn L, Dillon S, Crawford A, et al. Flow cytometric quantitation of the protective efficacy of dendritic cell based vaccines in a humanpapillomavirus type 16 murine challenge model[J]. J Virol Methods,2004,117(1) :9-18.

引证文献2

二级引证文献3

国外医学（妇产科学分册）
2004年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部